| 순번 | 년도 | 세포주 | 개수 | 조직 | 저자 | 논문제목 | 저널 |
| 1 | 1987 | SNU-C1, SNU-C2A, SNU-C2B, SNU-C4, SNU-C5 | 5 | Colorectal ca. | Park ~ Gazdar | Characteristics of cell lines established from human colorectal carcinoma | Cancer Res, 47: 6710-6718, 1987 |
| 2 | 1990 | SNU-1, SNU-5, SNU-16 | 3 | Gastric ca. | Park ~ Gazdar | Characteristics of cell lines established from human gastric carcinoma | Cancer Res, 50: 2773-2780, 1990 |
| 3 | 1995 | SNU-182, SNU-354, SNU-368, SNU-387, SNU-398, SNU-423, SNU-449, SNU-475 | 8 | HCC | Park ~ Kim | Characterization of cell lines established from human hepatocellular carcinoma. | Int J Cancer, 62: 276-282, 1995 |
| 4 | 1996 | SNU-739, SNU-761, SNU-878, SNU-886 | 4 | HCC | Kang ~ Park | Mutation of p53 gene in hepatocellular carcinoma cell lines with HBX DNA | Int. J. Cancer: 67,898-902 (1996) |
| 5 | 1999 | SNU-739, SNU-761, SNU-878, SNU-886 | - | HCC | Lee, Ku ~ Park | Establishment and characterization of four human hepatocellular carcinoma cell lines containing hepatitis B virus DNA | World J Gastroenterology. 1999, 5:289-295 |
| 6 | 1997 | SNU-8, SNU-119, SNU-251, SNU-563, SNU-840 | 5 | Ovarian ca. | Yuan ~ Park | Establishment and characterization of human ovarian carcinoma cell lines | Gynecol Oncol. 1997 Sep; 66(3): 378-387 |
| 7 | 1997 | SNU-17, SNU-487, SNU-523, SNU-682, SNU-703, SNU-778, SNU-902, SNU-1000, SNU-1005, SNU-1160, SNU-1245, SNU-1299 | 12 | Uterine cervical-carcinoma | Ku ~ Park | Establishment and Characterization of 12 uterine cervical-carcinoma cell lines: Common sequence variation in the E7 gene of HPV-16-positive cell lines. | Int J Cancer. 1997 Jul 17; 72(2):313-320 |
| 8 | 1997 | SNU-539, SNU-685, SNU-1077 | 3 | MMMT (malignant mixed Müllerian tumor) | Yuan ~ Park | Establishment and characterization of cell lines derived from uterine malignant mixed mullerian tumor | Gynecol Oncol. 1997 Sep; 66(3): 464-474 |
| 9 | 1997 | SNU-216, SNU-484, SNU-520, SNU-601, SNU-620, SNU-638, SNU-668, SNU-719 | 8 | Gastric ca. | Park ~ Kim | Establishment and characterization of human gastric carcinoma cell lines | Int J Cancer. 1997 Feb 7; 70(4):443-449 |
| 10 | 1998 | SNU-9, SNU-20, SNU-99, SNU-247, SNU-265, SNU-285, SNU-291, SNU-299, SNU-315, SNU-321, SNU-374, SNU-445, SNU-447, SNU-538, SNU-817, SNU-889, SNU-1103 | 17 | B-lymphoblastoid | Lee ~ Park | B-lymphoblastoid cell lines from cancer patients | In Vitro Cell Dev Biol, 1998, 34:97-100 |
| 11 | 1999 | SNU-46, SNU-585, SNU-899, SNU-1066, SNU-1076, SNU-1214 | 6 | Laryngeal ca. | Ku ~ Park | Establishment and characterization of human laryngeal squamous cell carcinoma cell lines | Laryngoscope., 1999 |
| 12 | 1999 | SNU-61, SNU-81, SNU-175, SNU-283, SNU-407, SNU-503, SNU-769A, SNU-769B, SNU-1033, SNU-1040, SNU-1047, SNU-1197 | 12 | Colorectal ca. | Oh, Ku ~ Park | Establishment and Characterization of 12 human colorectal carcinoma cell lines. | Int J Cancer, 81:902-910, 1999 |
| 13 | 2000 | SNU-228, SNU-267, SNU-328, SNU-349, SNU-1272 | 5 | Renal cell ca. | Shin, Ku ~ Park | Establishment and characterization of seven human renal cell carcinoma cell lines | BJU internaltional. 2000, 85:130-137 |
| 14 | 2001 | SNU-201, SNU-444, SNU-466, SNU-489, SNU-626, SNU-1105, SNU-738, SNU-791, SNU-1118 | 9 | Brain tumor | Shin ~ Park | Establishment and characterization of nine human brain tumor cell line | In Vitro Cell Dev. Bio., 2001, 37:625-628. |
| 15 | 2002 | SNU-213, SNU-324, SNU-410, SNU-494 | 4 | Pancreatic ca. | Ku ~ Park | Establishment and characterization of 4 human pancreatic carcinoma cell lines: Genetic alterations in the TGFBR2 gene but not in the MADH4 gene | Cell Tiss Res,2002, 204-214 |
| 16 | 2002 | SNU-245, SNU-308, SNU-478, SNU-869, SNU-1079, SNU-1196 | 6 | Biliary tract ca. | Ku ~ Park | Establishment and characterization of six human biliary tract cancer cell lines | Brit J Cancer, 2002, 87:187-193 |
| 17 | 2004 | SNU-620R-5-FU/1000; SNU-638R-5-FU/50000; SNU-668R-5-FU/4000; SNU-719R-5-FU/600, SNU-620R-DOX/300; SNU-668RDOX/50; SNU-719R-DOX/100, SNU-620R-CIS/2000; SNU-638R-CIS/400; SNU-668RCIS/400 | 10 | drug-resistant gastric ca. | Kang ~ Park | Identification of genes with differential expression in acquired drug-resistant gastric cancer cells using high-density oligonucleotide microarrays | Clin Cancer Res. 2004;10:272-284. |
| 18 | 2007 | SNU-80, SNU-373, SNU-790 | 3 | Thyroid cancer | Koh, Ku ~ Park | Establishment and characterization of cell lines from three human thyroid carcinomas: responses to all-trans-retinoic acid and mutations in the BRAF gene | Mol Cell Endocrinol, 2007;264:118-127 |
| 19 | 2010 | SNU-70, SNU-254, SNU-479, SNU-796, SNU-977, SNU-1181, SNU-1235, SNU-1406, SNU-1411, SNU-1460, SNU-1544, SNU-1684, SNU-1746 | 13 | Colorectal ca. | Ku ~ Park | Establishment and characterization of 13 human colorectal carcinoma cell lines: mutations of genes and expressions of drug-sensitivity genes and cancer stem cell markers | Carcinogenesis, 31:1003-1009, 2010 |
| 20 | 2011 | SNU-371, SNU-963, SNU-1327, SNU-1330, SNU-2292, SNU-2315 | 6 | Lung ca. | Ku ~ Park | Establishment and characterization of six human lung cancer cell lines: EGFR, p53 gene mutations and expressions of drug sensitivity genes | Cellular Onc., 34:45-54, 2011 |
| 21 | 2012 | SNU-NCC-19, SNU-NCC-20, SNU-NCC-24, SNU-NCC-59, SNU-1750, SNU-1967 | 6 | Gastric ca. | Ku ~ Park | Establishment and characterization of six human gastric carcinoma cell lines, including one naturally infected with Epstein-Barr virus | Cell Oncol (Dordr). 2012 Apr;35(2):127-36. |
| 22 | 2013 | SNU-306, SNU-334, SNU-1528, SNU-1553, SNU-1581, SNU-1958, SNU-2372 | 7 | Breast ca. | Ku ~ Park | Establishment and characterization of seven human breast cancer cell lines including two triple-negative cell lines | Int J Oncol. 2013 Dec;43(6):2073-81. |
| 23 | 2018 | SNU-2335A, SNU-2404A, SNU-2414A, SNU-2335D, SNU-2404B, SNU-2414B | 6 | Colorectal ca. | Kim, Ku ~ Park | Establishment and Characterization of Paired Primary and Peritoneal Seeding Human Colorectal Cancer Cell Lines: Identification of Genes That Mediate Metastatic Potential. | Transl Oncol . 2018 Oct;11(5):1232-1243 |
| 24 | 2019 | SNU-NCC-375, SNU-1460, SNU-1826, SNU-2446 | 4 | Colorectal ca. | Kim ~ Ku | Identification of a Novel Fusion Gene, FAM174A-WWC1, in Early-Onset Colorectal Cancer: Establishment and Characterization of Four Human Cancer Cell Lines from Early-Onset Colorectal Cancers | Transl Oncol. 2019 Jun 19;12(9):1185-1195. |
| 25 | 2019 | SNU-2466, SNU-2469, SNU-2485, SNU-2491, SNU-2543, SNU-2564, SNU-2570, SNU-2571, SNU-2608, SNU-2617 | 10 | Pancreatic ca. | Kim ~ Ku | Establishment and Characterization of 10 Human Pancreatic Cancer Cell Lines Including a HER2 Overexpressed Cell Line | Pancreas. 2019 Nov/Dec;48(10):1285-1293. |
| 26 | 2020 | SNU-1566, SNU-1983, SNU-2172, SNU-2297, SNU-2303, SNU-2353B, SNU-2359, SNU-2373B, SNU-2407, SNU-2423, SNU-2431, SNU-2465, SNU-2493, SNU-2536C, SNU-2621B, SNU-NCC-61, SNU-NCC-376, SNU-NCC-377 | 18 | Colorectal ca. | Kim ~ Ku | Establishment and characterization of 18 human colorectal cancer cell lines | Sci Rep. 2020 Apr 22;10(1):6801 |
| 27 | 2020 | SNU-2785(GIST-R1), SNU-3018B(GIST-R2m), SNU-2845B(GIST-R3), SNU-3069(GIST-R4ma), SNU-2979B(GIST-R5) | 5 | GIST | Cho ~ Ku | The role of novel fusion genes in human GIST cell lines derived from imatinib-resistant GIST patients: A therapeutic potential of fusion gene | Biochem Biophys Res Commun . 2020 Aug 27;529(3):699-706. |
| 28 | 2021 | SNU-3947-TO, SNU-4158-TO, SNU-4192-TO, SNU-4206-TO, SNU-4208-TO, SNU-4305-TO, SNU-4309-TO, SNU-4340-TO, SNU-4354-TO, SNU-4365-TO, SNU-4425-TO, SNU-4607-TO | 12 | Pancreatic ca. | Lee ~ Ku | Establishment of Patient-Derived Pancreatic Cancer Organoids from Endoscopic Ultrasound-Guided Fine-Needle Aspiration Biopsies | Gut Liver. 2021 Dec 17. |
| 29 | 2022 | SNU-4139S1, SNU-4139S3, SNU-4146S1T, SNU-4146S2, SNU-4146S3, SNU-4146S4, SNU-4146S4T, SNU-4376AS1T,SNU-4376AS2,SNU-4376AS3T,SNU-4376AS4,SNU-4398S1,SNU-4398S2,SNU-4398S4,SNU-4631AS1,SNU-4631AS4, SNU-4646S1T,SNU-4646S2T,SNU-4646S3T,SNU-4713S1,SNU-4713S1T,SNU-4713S3,SNU-4796S2, SNU-4139S1-TO,SNU-4139S2-TO,SNU-4139S3-TO,SNU-4139S4-TO,SNU-4146S1-TO,SNU-4146S2-TO,SNU-4146S3-TO,SNU-4146S4-TO,SNU-4351S1-TO,SNU-4351S2-TO,SNU-4351S3-TO,SNU-4351S4-TO, SNU-4374S1-TO,SNU-4374S2-TO,SNU-4374S3-TO,SNU-4374S4-TO,SNU-4376AS1-TO,SNU-4376AS3-TO,SNU-4376AS4-TO,SNU-4398S1-TO,SNU-4398S2-TO,SNU-4398S3-TO,SNU-4398S4-TO, SNU-4631AS1-TO,SNU-4631AS2-TO,SNU-4631AS3-TO,SNU-4631AS4-TO,SNU-4646S1-TO,SNU-4646S2-TO,SNU-4646S3-TO,SNU-4713S1-TO,SNU-4713S2-TO,SNU-4713S3-TO,SNU-4796S1-TO, SNU-4796S2-TO,SNU-4796S3-TO,SNU-4796S4-TO,SNU-4813S1-TO,SNU-4813S2-TO,SNU-4813S3-TO,SNU-4849S1-TO,SNU-4849S2-TO,SNU-4849S3-TO | 66 | Colorectal ca. | Kim ~ Ku | Multifocal Organoid Capturing of Colon Cancer Reveals Pervasive Intratumoral Heterogenous Drug Responses | Adv Sci (Weinh) . 2022 Feb;9(5):e2103360. |
| 30 | 2022 | SNU-2535, SNU-2550, SNU-2553, SNU-2556, SNU-2563, SNU-2585, SNU-2588, SNU-2589, SNU-2606, SNU-2612A, SNU-2627, SNU-2637, SNU-2641, SNU-2643, SNU-2657, SNU-2681, SNU-2689, SNU-2693, SNU-2708.1, SNU-2727, SNU-2741, SNU-2749, SNU-2778, SNU-2832, SNU-2867, SNU-2887, SNU-2964, SNU-3023 | 28 | Lung ca. | Seo, Kim ~ Ku | Culture and multiomic analysis of lung cancer patient-derived pleural effusions revealed distinct druggable molecular types | Sci Rep. 2022 Apr 15;12(1):6345. |
| 31 | 2022 | SNU-6685A, SNU-6685B, SNU-6685C, SNU-6685D, SNU-6685E, SNU-6685F, SNU-6685AT, SNU-6685BT, SNU-6685CT, SNU-6685DT, SNU-6685ET, SNU-6685FT, SNU-6685A-TO, SNU-6685B-TO, SNU-6685C-TO, SNU-6685D-TO, SNU-6685E-TO, SNU-6685F-TO | 18 | Colorectal ca. | Kim ~ Ku | Multifocal organoids reveal clonal associations between synchronous intestinal tumors with pervasive heterogeneous drug responses | NPJ Genom Med. 2022 Jul 19;7(1):42. |
| 32 | 2022 | SNU-4351S1-5-TO, SNU-4351S1-7-TO, SNU-4351S2-3-TO, SNU-4351S2-4-TO, SNU-4351S3-1-TO, SNU-4351S3-2-TO, SNU-4351S3-7-TO, SNU-4351S3-8-TO, SNU-4351S4-1-TO, SNU-4351S4-2-TO, SNU-4351S4-3-TO, SNU-4351S4-4-TO, SNU-4351S4-5-TO, SNU-4351S4-6-TO, SNU-4351S4-7-TO | 15 | Colorectal ca. | Song ~ Ku | Colon cancer organoids using monoclonal organoids established in four different lesions of one cancer patient reveal tumor heterogeneity and different real-time responsiveness to anti-cancer drugs | Biomed Pharmacother. 2022 Aug:152:113260. |
| 33 | 2023 | SNU-3978, SNU-3980, SNU-3987, SNU-4026, SNU-4054, SNU-4071, SNU-4072, SNU-4098, SNU-4116, SNU-4137, SNU-4138, SNU-4177, SNU-4210, SNU-4254, SNU-4312, SNU-4327, SNU-4484, SNU-4514, SNU-4546, SNU-4638, SNU-4689, SNU-4702, SNU-4954, SNU-4982, SNU-5026, SNU-5262 | 26 | Brain tumor | Kim ~ Ku | Patient-derived glioblastoma cell lines with conserved genome profiles of the original tissue | Sci Data. 2023 Jul 12;10(1):448-463 |
| 34 | 2024 | SNU-2543-TO, SNU-3898-TO, SNU-3912-TO, SNU-3923-TO, SNU-3926-TO, SNU-3947-TO, SNU-3997-TO, SNU-4158-TO, SNU-4192-TO, SNU-4206-TO, SNU-4208-TO, SNU-4242-TO, SNU-4243-TO, SNU-4305-TO, SNU-4309-TO, SNU-4340-TO, SNU-4354-TO, SNU-4365-TO, SNU-4378-TO, SNU-4425-TO, SNU-4457-TO, SNU-4461-TO, SNU-4482-TO, SNU-4525-TO, SNU-4557-TO, SNU-4607-TO, SNU-4779-TO, SNU-4837-TO, SNU-4863-TO, SNU-4871-TO, SNU-4874-TO, SNU-4893-TO, SNU-4894-TO, SNU-5177-TO, SNU-5420-TO, SNU-5577-TO | 36 | Pancreatic ca. | Kim ~ Ku | Establishment, characterization, and biobanking of 36 pancreatic cancer organoids: prediction of metastasis in resectable pancreatic cancer | Cell Oncol (Dordr). 2024 Apr. e-pub ahead of print |
